Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Sousuke Hashida is a leading gynecologic oncologist whose research focuses on refining surgical approaches for early-stage cervical and endometrial cancers. His work critically evaluates the comparative effectiveness of minimally invasive surgery (MIS) versus abdominal radical hysterectomy (ARH), addressing a pivotal concern in the field: the potential for higher recurrence rates associated with MIS. In his most cited 2022 study (8 citations), Hashida provided a direct prognosis comparison, contributing essential data to a heated clinical debate. He has also pioneered technical innovations, notably developing robot-assisted modified radical hysterectomy with lymphatic vessel removal using indocyanine green (ICG) for sentinel lymph node mapping. This method, detailed in a 2022 paper (3 citations), emphasizes enhanced safety and precision. Most recently, his 2024 investigation into oncologic outcomes after sentinel lymph node biopsy (SNB) in cervical cancer (2 citations) addresses a critical gap in the literature, evaluating whether this less invasive staging technique compromises survival. Through these contributions, Hashida is actively shaping the evidence base for surgical decision-making, balancing oncologic safety with the benefits of minimally invasive approaches.